---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-010475"
form_type: "8-K"
ticker: "ASMB"
cik: "0001426800"
company_name: "ASSEMBLY BIOSCIENCES, INC."
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T09:51:29.968352+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Assembly Biosciences stockholders approve reverse stock split; Board sets ratio at 1-for-12

## Summary
- Stockholders approved a range of 1-for-7 to 1-for-17 reverse stock split; Board selected 1-for-12 ratio.
- Approval of share issuance to Gilead Sciences under October 2023 Stock Purchase Agreement (16.2M votes for).
- Reverse split expected to be effectuated as soon as practicable after the January 31, 2024 special meeting.
- Adjournment proposal approved with 28M votes for, 9.7M against.

## SEC filing metadata
- accession: 0000950170-24-010475
- form_type: 8-K
- ticker: ASMB
- cik: 0001426800
- company_name: ASSEMBLY BIOSCIENCES, INC.
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1426800/000095017024010475/0000950170-24-010475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1426800/000095017024010475/asmb-20240131.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-010475
- JSON: https://secwatch.observer/filing/0000950170-24-010475.json
- Plain text: https://secwatch.observer/filing/0000950170-24-010475.txt

## Key facts
- Shareholder Votes
  ASSEMBLY BIOSCIENCES, INC. shareholders approved Reverse stock split at ratio from 1-for-7 to 1-for-17 at the 2024-01-31 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2024-01-31
  source text: The stockholders approved a series of alternate amendments to the Company's Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's Board of Directors (the "Board"), a reverse stock split of the Company's common stock at a ratio to be determined by the Board within a range of 1-for-7 to 1-for-17 (or any number in between) without reducing the authorized number of shares of the common stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1426800/000095017024010475/0000950170-24-010475-index.htm
- Shareholder Votes
  ASSEMBLY BIOSCIENCES, INC. shareholders approved Adjournment of the Special Meeting to solicit additional proxies if necessary at the 2024-01-31 meeting.
  - Outcome: passed
  - Meeting: 2024-01-31
  source text: The stockholders approved an adjournment of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposals.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1426800/000095017024010475/0000950170-24-010475-index.htm
- Shareholder Votes
  ASSEMBLY BIOSCIENCES, INC. shareholders approved Issuance of shares of common stock to Gilead Sciences, Inc. pursuant to Nasdaq Listing Rules 5635(a) and 5635(b) at the 2024-01-31 meeting.
  - Outcome: passed
  - Meeting: 2024-01-31
  source text: The stockholders approved, subject to certain conditions, the issuance of shares of common stock to Gilead Sciences, Inc. ("Gilead") pursuant to Nasdaq Listing Rules 5635(a) and 5635(b).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1426800/000095017024010475/0000950170-24-010475-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.